기관회원 [로그인]
소속기관에서 받은 아이디, 비밀번호를 입력해 주세요.
개인회원 [로그인]

비회원 구매시 입력하신 핸드폰번호를 입력해 주세요.
본인 인증 후 구매내역을 확인하실 수 있습니다.

회원가입
서지반출
원발성폐암의 방사선치료
[STEP1]서지반출 형식 선택
파일형식
@
서지도구
SNS
기타
[STEP2]서지반출 정보 선택
  • 제목
  • URL
돌아가기
확인
취소
  • 원발성폐암의 방사선치료
저자명
이도행
간행물명
대한방사선의학회지
권/호정보
1974년|10권 1호|pp.54-64 (11 pages)
발행정보
대한영상의학회
파일정보
정기간행물|
PDF텍스트
주제분야
기타
이 논문은 한국과학기술정보연구원과 논문 연계를 통해 무료로 제공되는 원문입니다.
서지반출

기타언어초록

With medium energy radiation treatment by 60Co teletherapy was observed primary lung cancer of 62 cases and adjunct change in the chest. The radiation therapeutic effects biased by initiation period of progression of tumor itself is well known facts. Of these 62 patients, 42 had completed a course of treatment with total tumor doses ranged from 4,000 rads to 7,000 rads. Patients were fractionally treated five times per week with weekly tumor dose of 1,000 rads. Among the 42 patients of sex incidence, 36 cases(86%) were male, and 6 patients(14%) were female. The maximum cancer incidence was found in 7th decade being in 16 patients (38.1%). Histopathological confirmation of 27 cases (64.2%) of primary pulmonary cancer is as follows; 9 patients (33.3%) of squamous cell carcinoma, 8 cases(28.6%) of undifferentiated cell carcinoma, 6 cases(22.2%) of oat cell carcinoma, 3 patients(11.1%) of adenocarcinoma and 1 case was carcinoid type of malignant bronchial adenoma. During the cours of treatment by weekly check-up of plain chest roentgenogram the onset of radiation pneumonitis was elucidated in 2-3 months following initiation of treatment and occurrence of fibrosis is individualized in 3-6 months in 16 cases of lung cancer among 62 cases. Follow-up about half of total cases of 1 year survival was 26.6 per cent. Lengthiest survival was in squamous cell carcivoma of well differentiated group and in undifferentiated carcinoma relatively short survival was seen. Supportive surgical and chemotherapeutic treatment seem to increase survival rate.